Vascutek and Bolton Medical Merge as Terumo Aortic

 

April 23, 2018—Vascutek Ltd. and Bolton Medical, Inc., subsidiaries of Terumo Corporation of Japan, have combined into a single business, known as Terumo Aortic, to grow its presence in the global aortic and vascular implants market. Terumo acquired Vascutek in 2002 and Bolton Medical in 2017.

As a developer of devices to treat aortic disease, Terumo Aortic will have a combined revenue of approximately $200 million and more than 1,100 employees worldwide. The primary research and manufacturing facilities will remain in Glasgow, Scotland, and Sunrise, Florida. During the past year, Vascutek and Bolton Medical have consolidated their complementary offerings and have created an integrated research and innovation strategy for Terumo Aortic.

The combined business offers a portfolio of surgical grafts for abdominal, cardiothoracic, and peripheral applications, as well as hybrid and catheter-based stent graft systems for abdominal and thoracic aortic aneurysms.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.